We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Illumina CLIA lab subscribes to Clarity LIMS to augment existing informatics infrastructure

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

GenoLogics Life Science Software, a leading provider of laboratory information management systems (LIMS) designed for today's omics labs, has announced that the Illumina Clinical Services Laboratory has signed a subscription license agreement for Clarity LIMS.  Under the agreement, Clarity LIMS, alongside internally developed systems within the CLIA-certified, CAP-accredited laboratory at Illumina, will be used to support Illumina's TruSight Individual Genome Sequencing (IGS) test.

"In the clinical laboratory environment, informatics tools to support compliance, such as the data and workflow enforcement features offered in Clarity LIMS, are crucial to ensuring high quality throughout the laboratory process," said Marc Laurent, Director of Commercial Services for Illumina. "We are confident that Clarity LIMS will help us to maintain our high quality standards and serve physicians and patients as the demand for our sequencing services grow."

Clarity LIMS is an intuitive lab management system that combines information management essentials for CLIA-certified and other regulated labs with a clear and simple interface. Specifically, Clarity LIMS assists these organizations with workflow enforcement, adherence to standard operating procedures and management of the specific complexities associated with next-generation sequencing (NGS). All of these capabilities can be implemented within a few weeks, making Clarity LIMS unparalleled in the industry.

"We are pleased to be part of the Illumina CLIA laboratory's' robust informatics ecosystem," says Michael Ball, CEO of GenoLogics. "An increasing number of CLIA laboratories are taking advantage of our flexible Clarity LIMS subscription licensing to support the growing sequencing services business."